Navidea Biopharmaceuticals Inc (OTCPK:NAVB)
$ 0.036 -0.002 (-5.26%) Market Cap: 3.60 Mil Enterprise Value: 998,000.00 PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Navidea Biopharmaceuticals Inc Annual Shareholders Meeting Transcript

Sep 10, 2020 / 01:00PM GMT
Release Date Price: $2.88 (-2.37%)
Operator

Welcome to the 2020 Annual Meeting for Navidea Biopharmaceuticals. Our host for today's call is Michael Rice, Chairman of the Board. (Operator Instructions)

I will now turn the call over to your host, Mr. Rice. You may begin, sir.

Y. Michael Rice
Navidea Biopharmaceuticals, Inc. - Independent Chairman of the Board

Thank you. Good morning, fellow stockholders. I am Michael Rice, Chairman of the Board of Directors of Navidea Biopharmaceuticals. I will be the Chairman of this meeting.

To support the health and well-being of our stockholders, the employees, their families, due to the public health impact of the coronavirus pandemic, we are holding this meeting virtually via the webcast. The agenda for this meeting is set forth on your screen and in the Notice of the Meeting.

The 2020 Annual Meeting of Stockholders is now called to order. First, let me welcome you to Navidea's 2020 Annual Meeting, and I'm pleased that you could join us today. I'd like to introduce you to the other directors of the company who are present by phone today:

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot